Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

0.93
Delayed Data
As of Nov 22
 +0.03 / +3.33%
Today’s Change
0.70
Today|||52-Week Range
2.89
-13.89%
Year-to-Date
Institutional investors purchased a net $3.3 thousand shares of GENE during the quarter ended June 2017, and now own 10.48% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

9/30/2017RENAISSANCE TECHNOLOGIES LLC  Bought 47.1 Thousand shares of Genetic Technologies Ltd
9/30/2017BANK OF AMERICA, NA (PRIVATE BAN...  Bought 435.00 shares of Genetic Technologies Ltd
9/30/2017UBS SECURITIES LLC  Bought 368.00 shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Renaissance Technologies LLC6.09%989,280781,531+47,100+5.00%
Heights Capital Management, Inc.3.10%502,768397,187-49,664-8.99%
KCG Americas LLC0.53%85,96067,908+85,960--
Bank of America, NA (Private Bank...0.37%60,72147,970+435+0.72%
Alpine Global Management LLC0.26%42,22033,35400.00%
UBS Securities LLC0.07%10,6518,414+368+3.58%
Cutler Group LP0.03%4,8003,79200.00%
KMS Financial Services, Inc.0.02%2,7502,17300.00%
Morgan Stanley Smith Barney LLC (...0.01%1,5001,18500.00%
UBS Financial Services, Inc.0.01%1,00079000.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change